| Financial Year |
March 31 2023 |
| Monetary Funds |
251,850,656.66 |
| Held-for-trading Financial Assets |
70,016,131.79 |
| Notes Receivable |
8,038,255.00 |
| Accounts Receivable |
18,666,042.29 |
| Advances to Suppliers |
1,923,197.94 |
| Other Receivables |
2,003,898.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,116,528.00 |
| Dividend Receivable |
-- |
| Inventories |
6,686,325.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,997,399.66 |
| Total Current Assets |
365,181,907.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
197,718,883.73 |
| Under-construction Projects |
342,972,414.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
80,420,342.97 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,057,594.32 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
157,630.00 |
| Sub-Total of Non-Current Assets |
2,129,103,105.70 |
| Total Assets |
2,494,285,012.77 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
18,630,646.25 |
| Accounts Payable |
7,142,398.98 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
872,887.28 |
| Taxes Payable |
6,670,682.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
165,076.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
4,823,991.14 |
| Sub-Total of Current Liabilities |
40,028,691.32 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
271,909,316.37 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
277,157,216.37 |
| Total Liabilities |
317,185,907.69 |
| Paid-In Capital(Or Share Stock) |
405,000,000.00 |
| Capital Surplus |
536,902,954.94 |
| Surplus Reserve |
75,584,989.83 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
327,306,546.53 |
| Minority Stockholder's Interest |
5,112,726.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,171,986,378.39 |
| Owner's Equity（Stockholder's Equity） |
2,177,099,105.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,494,285,012.77 |
